Regeneron Pharmaceuticals REGN Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's total current assets?
- Regeneron Pharmaceuticals (REGN) reported total current assets of $18.21B in Q1 2026.
- How has Regeneron Pharmaceuticals's total current assets changed year-over-year?
- Regeneron Pharmaceuticals's total current assets increased by 3.6% year-over-year, from $17.57B to $18.21B.
- What is the long-term trend for Regeneron Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's total current assets has grown at a 13.0% compound annual growth rate (CAGR), from $9.78B to $18.02B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.